323 related articles for article (PubMed ID: 24517496)
1. Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India.
Mittal N; Gupta M; Singla M
Cutan Ocul Toxicol; 2014 Dec; 33(4):289-93. PubMed ID: 24517496
[TBL] [Abstract][Full Text] [Related]
2. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
Jose J; Rao PG
Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
[TBL] [Abstract][Full Text] [Related]
3. Trends in culprit drugs and clinical entities in cutaneous adverse drug reactions: a retrospective study.
Wang F; Zhao YK; Li M; Zhu Z; Zhang X
Cutan Ocul Toxicol; 2017 Dec; 36(4):370-376. PubMed ID: 28423957
[TBL] [Abstract][Full Text] [Related]
4. An observational study of cutaneous adverse drug reactions in a teaching hospital.
Chopra D; Sharma V; Kapoor R; Dwivedi S
Int J Clin Pharm; 2015 Dec; 37(6):996-9. PubMed ID: 26238222
[TBL] [Abstract][Full Text] [Related]
5. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous cutaneous adverse drug reaction reports-An analysis of a 10-year dataset in Singapore.
Wong SX; Tham MY; Goh CL; Cheong HH; Chan SY
Pharmacol Res Perspect; 2019 Apr; 7(2):e00469. PubMed ID: 30911397
[TBL] [Abstract][Full Text] [Related]
7. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Choon SE; Lai NM
Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
[TBL] [Abstract][Full Text] [Related]
8. Adverse cutaneous drug reactions among hospitalized patients: five year surveillance.
Turk BG; Gunaydin A; Ertam I; Ozturk G
Cutan Ocul Toxicol; 2013 Mar; 32(1):41-5. PubMed ID: 22812902
[TBL] [Abstract][Full Text] [Related]
9. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
Geer MI; Koul PA; Tanki SA; Shah MY
J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of cutaneous adverse drug reactions in Southwest China: an 11-year retrospective survey on in-patients of a dermatology ward.
Zhong H; Zhou Z; Wang H; Niu J; Chen W; Song Z; Hao F
Dermatitis; 2012; 23(2):81-5. PubMed ID: 22653124
[TBL] [Abstract][Full Text] [Related]
11. Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital.
Khan LM; Al-Harthi SE; Saadah OI; Al-Amoudi AB; Sulaiman MI; Ibrahim IM
Saudi Med J; 2012 Aug; 33(8):863-8. PubMed ID: 22886119
[TBL] [Abstract][Full Text] [Related]
12. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun.
Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P
Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous adverse drug reaction profile in a tertiary care out patient setting in eastern India.
Saha A; Das NK; Hazra A; Gharami RC; Chowdhury SN; Datta PK
Indian J Pharmacol; 2012; 44(6):792-7. PubMed ID: 23248414
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous adverse drug reactions: clinical pattern and causative agents--a 6 year series from Chandigarh, India.
Sharma VK; Sethuraman G; Kumar B
J Postgrad Med; 2001; 47(2):95-9. PubMed ID: 11832597
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Cutaneous Adverse Drug Reactions (ADR) Reported at an ADR Monitoring Center of a Tertiary Care Teaching Institute in Central India.
Chindhalore CA; Gupta AV; Dakhale GN; Srivastava A
Cureus; 2024 Feb; 16(2):e53706. PubMed ID: 38455795
[TBL] [Abstract][Full Text] [Related]
16. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
[TBL] [Abstract][Full Text] [Related]
17. Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study.
Kurian J; Mathew J; Sowjanya K; Chaitanya KR; Ramesh M; Sebastian J; Narayanappa D
Indian J Pediatr; 2016 May; 83(5):414-9. PubMed ID: 26916890
[TBL] [Abstract][Full Text] [Related]
18. Adverse drug reactions experience in a teaching hospital in Jordan.
Alsbou M; Alzubiedi S; Alzobi H; Samhadanah NA; Alsaraireh Y; Alrawashdeh O; Aqel A; Al-Salem K
Int J Clin Pharm; 2015 Dec; 37(6):1188-93. PubMed ID: 26286340
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous adverse drug reactions with fixed-dose combinations: Special reference to self-medication and preventability.
Tripathy R; Pattnaik KP; Dehury S; Patro S; Mohanty P; Sahoo SS; Mohanty S
Indian J Pharmacol; 2018; 50(4):192-196. PubMed ID: 30505055
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional study of cutaneous drug reactions in a private dental college and government medical college in eastern India.
Chattopadhyay C; Chakrabarti N
Niger J Clin Pract; 2012; 15(2):194-8. PubMed ID: 22718172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]